TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
OMER

Omeros Corporation

Healthcare · Biotechnology

20.10$ -0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement OMER
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% – – – –
– – 1,349.2% 2,159.1% 1,506.2% 1,484.0% 696.3% 0.3% 1,145.4% 4,958.8% 7.7% 3.4% 1.7% 1.7% 2.4% 2.2% 1.5% – – – –
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 99.7% -1,045.4% -4,858.8% 92.3% 96.6% 98.3% 98.3% 97.6% -2.2% -1.5% – – – –
– 10,264.0% 828.0% 1,525.6% 1,172.4% 1,114.7% 524.3% 530.1% 2,268.6% 8,895.4% 358.1% 121.8% 85.8% 300.9% 98.1% 145.8% 131.2% – – – –
– 1,812.5% 540.7% 670.5% 365.2% 415.5% 181.6% 182.4% 988.7% 4,193.1% 255.0% 103.6% 80.3% 164.8% 57.8% 98.5% 60.6% – – – –
– 12,076.5% 1,368.7% 2,196.2% 1,537.5% 1,530.2% 705.9% 712.5% 3,257.3% 13,088.5% 619.6% 227.0% 166.0% 474.0% 154.3% 210.4% 190.3% – – – –
– -11,976.5% -1,268.7% -2,096.2% -1,437.5% -1,430.2% -605.9% -612.5% -3,157.3% -12,988.5% -527.3% -130.4% -67.7% -375.7% -56.7% -212.6% -191.8% – – – –
– 45.5% 7.9% 28.6% 152.5% 72.9% 41.6% 28.7% 147.9% 643.8% 26.4% 18.8% 17.0% 54.4% 20.3% 36.2% 21.7% – – – –
– -11,388.5% -1,200.8% -2,036.5% -1,308.0% -1,316.7% -589.3% -638.4% -2,487.3% -13,668.5% -555.9% -160.4% -82.5% -467.7% -75.6% -266.1% -211.6% – – – –
– 135.0% 1.4% 60.4% 22.9% -40.6% 25.1% 25.6% 183.8% 544.9% 32.5% 20.3% 18.4% -43.3% 20.1% -31.5% -404.1% – – – –
– -11,388.5% -1,200.8% -2,036.5% -1,460.5% -1,389.6% -631.0% -638.4% -2,487.3% -13,668.5% -555.9% -160.4% -82.5% -424.4% -75.6% -187.0% -123.1% – – – –
– -11,227.0% -1,173.4% -2,059.1% -1,276.7% -1,294.3% -579.7% -604.4% -2,320.5% -12,964.2% -527.9% -140.9% -64.6% -410.0% -53.7% -227.6% -188.3% – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?